As of May 01
| +0.11 / +0.47%|
The 7 analysts offering 12-month price forecasts for Sagent Pharmaceuticals Inc have a median target of 30.00, with a high estimate of 38.00 and a low estimate of 27.00. The median estimate represents a +28.10% increase from the last price of 23.42.
The current consensus among 9 polled investment analysts is to Hold stock in Sagent Pharmaceuticals Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.